- Home
- ACTU vs MHLD Comparison
ACTU vs MHLD Comparison
Compare ACTU & MHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- MHLD
- Stock Information
- Founded
- ACTU 2015
- MHLD 2007
- Country
- ACTU United States
- MHLD Bermuda
- Employees
- ACTU N/A
- MHLD N/A
- Industry
- ACTU
- MHLD Property-Casualty Insurers
- Sector
- ACTU
- MHLD Finance
- Exchange
- ACTU NYSE
- MHLD Nasdaq
- Market Cap
- ACTU 153.1M
- MHLD 159.6M
- IPO Year
- ACTU 2024
- MHLD 2008
- Fundamental
- Price
- ACTU $8.55
- MHLD $1.84
- Analyst Decision
- ACTU
- MHLD
- Analyst Count
- ACTU 0
- MHLD 0
- Target Price
- ACTU N/A
- MHLD N/A
- AVG Volume (30 Days)
- ACTU 48.7K
- MHLD 80.1K
- Earning Date
- ACTU 11-21-2024
- MHLD 11-15-2024
- Dividend Yield
- ACTU N/A
- MHLD N/A
- EPS Growth
- ACTU N/A
- MHLD N/A
- EPS
- ACTU N/A
- MHLD N/A
- Revenue
- ACTU N/A
- MHLD $96,352,000.00
- Revenue This Year
- ACTU N/A
- MHLD N/A
- Revenue Next Year
- ACTU N/A
- MHLD N/A
- P/E Ratio
- ACTU N/A
- MHLD N/A
- Revenue Growth
- ACTU N/A
- MHLD 38.31
- 52 Week Low
- ACTU $5.51
- MHLD $1.19
- 52 Week High
- ACTU $10.16
- MHLD $2.55
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- MHLD 59.65
- Support Level
- ACTU N/A
- MHLD $1.59
- Resistance Level
- ACTU N/A
- MHLD $1.73
- Average True Range (ATR)
- ACTU 0.00
- MHLD 0.09
- MACD
- ACTU 0.00
- MHLD 0.02
- Stochastic Oscillator
- ACTU 0.00
- MHLD 75.61
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.